Biogen Inc (NASDAQ:BIIB)

Delayed Data
As of Mar 23
 -11.76 / -4.33%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 30 analysts offering 12-month price forecasts for Biogen Inc have a median target of 393.50, with a high estimate of 430.00 and a low estimate of 289.00. The median estimate represents a +51.27% increase from the last price of 260.13.

Analyst Recommendations

The current consensus among 33 polled investment analysts is to Buy stock in Biogen Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.49%
Growthannually 13.84%


Growthquarterly -4.90%
Growthannually 5.79%
Key to the earnings and sales forecast charts.